Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with latest updates, and special features on late-stage and discontinued projects.
https://www.reportscorner.com/reports/15415/Kidney-Cancer-(Renal-Cell-Cancer)---Pipeline-Review,-H1-2013/
2. DescriptionDescription
Reports Cornerwww.reportscorner.com
Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) -
Pipeline Review, H1 2013', provides an overview of the
indication's therapeutic pipeline. This report provides information
on the therapeutic development for Kidney Cancer (Renal Cell
Cancer), complete with latest updates, and special features on
late-stage and discontinued projects.
3. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) -
Pipeline Review, H1 2013', provides an overview of the
indication's therapeutic pipeline. This report provides information
on the therapeutic development for Kidney Cancer (Renal Cell
Cancer), complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Kidney Cancer (Renal
Cell Cancer). Kidney Cancer (Renal Cell Cancer) - Pipeline Review,
Half Year is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered
based on the availability and relevance of data for the indicated
disease.
4. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Scope
- A snapshot of the global therapeutic scenario for Kidney Cancer
(Renal Cell Cancer).
- A review of the Kidney Cancer (Renal Cell Cancer) products
under development by companies and universities/research
institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development
ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.
- Coverage of the Kidney Cancer (Renal Cell Cancer) pipeline on
the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
5. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Reasons to buy
- Identify and understand important and diverse types of
therapeutics under development for Kidney Cancer (Renal Cell
Cancer).
- Identify emerging players with potentially strong product
portfolio and design effective counter-strategies to gain
competitive advantage.
- Plan mergers and acquisitions effectively by identifying players
of the most promising pipeline.
- Devise corrective measures for pipeline projects by
understanding Kidney Cancer (Renal Cell Cancer) pipeline depth
and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects
to enhance and expand business potential and scope.
6. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
- Modify the therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove them from
pipeline.
portfolio by identifying discontinued projects and understanding
the factors that drove them from pipeline.
7. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
Table of Contents
Table of Contents 2
Introduction 7
Kidney Cancer (Renal Cell Cancer) Overview 8
Therapeutics Development 9
Kidney Cancer (Renal Cell Cancer) Therapeutics under Development by Companies 11
Kidney Cancer (Renal Cell Cancer) Therapeutics under Investigation by Universities/Institutes 18
Late Stage Products 21
Mid Clinical Stage Products 22
Early Clinical Stage Products 23
Discovery and Pre-Clinical Stage Products 24
Kidney Cancer (Renal Cell Cancer) Therapeutics - Products under Development by Companies 25
Kidney Cancer (Renal Cell Cancer) Therapeutics - Products under Investigation by Universities/Institutes
34
8. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
Companies Involved in Kidney Cancer (Renal Cell Cancer) Therapeutics Development 37
Kidney Cancer (Renal Cell Cancer) - Therapeutics Assessment 115
Drug Profiles 122
Kidney Cancer (Renal Cell Cancer) Therapeutics - Drug Profile Updates 366
Kidney Cancer (Renal Cell Cancer) Therapeutics - Discontinued Products 454
Kidney Cancer (Renal Cell Cancer) Therapeutics - Dormant Products 457
Kidney Cancer (Renal Cell Cancer) - Product Development Milestones 466
Appendix 476
9. For more informationFor more information
Reports Cornerwww.reportscorner.com
For more information please visit our website
https://www.reportscorner.com/reports/15415/Kidney-Cancer-(Renal-Cell-Cancer)---
Pipeline-Review,-H1-2013/
